Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis

NCT03993262 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.

NCT NCT03993262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03993262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
Lead sponsor
Jena University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
May 13, 2020
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune encephalitis